This inventor holds 1 USPTO granted patent. Top assignee: Lava Therapeutics N.v.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: David Lutje Hulsik: Innovator in Antibody Research
Introduction
David Lutje Hulsik is a prominent inventor based in Utrecht, Netherlands. He has made significant contributions to the field of medical research, particularly in the development of antibodies for therapeutic applications. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
David Lutje Hulsik holds a patent for "Antibodies that bind PSMA and gamma-delta T cell receptors." This invention relates to antibodies capable of binding human PSMA and a human Vγ9Vδ2 T cell receptor. The patent also encompasses pharmaceutical compositions that include these antibodies and their uses for medical treatment. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
David is associated with Lava Therapeutics N.V., a company dedicated to developing innovative immunotherapies. His role at the company allows him to leverage his expertise in antibody research to contribute to groundbreaking medical solutions.
Collaborations
David has collaborated with notable colleagues, including Robertus Cornelis Roovers and Johannes Jelle Van Der Vliet. These partnerships enhance the research and development efforts within the field of antibody therapies.
Conclusion
David Lutje Hulsik is a key figure in the realm of antibody research, with a focus on innovative medical treatments. His contributions through patents and collaborations reflect his dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile